Execution, clearing, reporting – of the three strands of over-the-counter derivatives reform agreed by the Group of 20 (G-20) nations in 2009, dealers could probably have lived with the last two. The market had already been moving towards wider use of central counterparties – although admittedly, just for interdealer trades – and regulatory reporting will not fundamentally affect the economics of the business.
Rules about how and where OTC products are traded are a different matter. They threate
The week on Risk.net, October 6-12, 2017Receive this by email